Differential Expression of CD79B, CD19, and PD‐L1 in de Novo and Transformed CD20‐Negative Large B‐Cell Lymphomas

Documenti analoghi

• Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma
  di: Swetha Kambhampati Thiruvengadam, et al.
  Pubblicazione: (2024)
• Daratumumab for CD20 − CD38 + Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
  di: ZeTong Hong, et al.
  Pubblicazione: (2025)
• Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐ MIND Study
  di: Koji Izutsu, et al.
  Pubblicazione: (2026)
• Treatments and Outcomes of Newly Diagnosed CD5‐Positive Diffuse Large B‐Cell Lymphoma: A Multi‐Institutional Observational Study
  di: Yuma Nato, et al.
  Pubblicazione: (2025)
• Widespread benign HNF1β‐positive solid nests from the urethral diverticulum to the bladder neck: Is it a mesonephric remnant?
  di: Takahiro Kirisawa, et al.
  Pubblicazione: (2024)